NOVEL DRUGS IN FOLLICULAR LYMPHOMA

Follicular lymphoma(FL) is the most common indolent non-Hodgkin lymphoma and constitutes 15% to 30% of lymphoma diagnoses. The natural history of the disease is characterized by recurrent relapses and progressively shorter remissions with a median survival of 10yrs. The impossibility of a chieving a...

Full description

Bibliographic Details
Main Authors: Giuseppe Rossi, Antonella Anastasia
Format: Article
Language:English
Published: PAGEPress Publications 2016-11-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/2707